Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Effect of osteoporosis medications on fracture healing
V. Hegde
, J. E. Jo
, P. Andreopoulou
, J. M. Lane
Research output
:
Contribution to journal
›
Review article
›
peer-review
66
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Effect of osteoporosis medications on fracture healing'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Accelerated Healing
16%
Anabolic Agents
16%
Anti-osteoporosis Medication
16%
Antiresorptive
33%
Biomechanical Properties
66%
Bisphosphonates
33%
Bone Formation
16%
Bone Healing
16%
Bone Maturity
16%
Bone Mineralization
16%
Bone Remodeling
16%
Calcitonin
33%
Callus
33%
Callus Density
16%
Callus Formation
16%
Callus Remodeling
33%
Callus Volume
33%
Cartilage Callus
16%
Cartilage Formation
16%
Clinical Data
16%
Clinical Model
16%
Delayed Repair
16%
Denosumab
33%
Distal Radius Fracture
16%
Drug Effects
16%
Endochondral
16%
Enhanced Healing
16%
Estrogen
16%
Fracture Healing
100%
Fragility Fracture
50%
Intact Parathyroid Hormone (iPTH)
33%
Mechanical Strength
16%
Osteoporosis
50%
Osteoporosis Medication
100%
Osteoporosis Treatment
16%
Osteoporotic Bone
33%
Pelvic Fracture
16%
Pharmacologic Agents
16%
Raloxifene
16%
Spine Surgery
16%
Strontium Ranelate
33%
Trabecular Bone
16%
Vitamin D
16%
Medicine and Dentistry
Anabolic Agent
14%
Bisphosphonate
28%
Bone Healing
14%
Bone Mineralization
14%
Bone Remodeling
14%
Calcitonin
28%
Callus
100%
Cartilage
14%
Clinical Study
14%
Denosumab
28%
Distal Radius Fracture
14%
Drug Effect
14%
Estrogen
14%
Fracture Healing
100%
Fragility Fracture
42%
Maturation
14%
Mineralization
14%
Osteoplasty
14%
Osteoporosis
100%
Parathyroid Hormone
28%
Pelvis Fracture
14%
Prospective Study
14%
Raloxifene
14%
Spine Surgery
14%
Strontium Ranelate
28%
Trabecula
14%
Vitamin D
14%
Pharmacology, Toxicology and Pharmaceutical Science
Anabolic Steroid
14%
Bisphosphonic Acid Derivative
28%
Calcitonin
28%
Callus
100%
Clinical Study
14%
Denosumab
28%
Distal Radius Fracture
14%
Estrogen
14%
Fracture Healing
100%
Fragility Fracture
42%
Parathyroid Hormone
28%
Pelvis Fracture
14%
Prospective Study
14%
Raloxifene
14%
Strontium Ranelate
28%
Vitamin D
14%
Nursing and Health Professions
Anabolic Agent
14%
Bisphosphonic Acid Derivative
28%
Calcitonin
28%
Callus
100%
Denosumab
28%
Distal Radius Fracture
14%
Estrogen
14%
Fracture Healing
100%
Fragility Fracture
42%
Parathyroid Hormone
28%
Pelvis Fracture
14%
Raloxifene
14%
Spine Surgery
14%
Strontium Ranelate
28%
Vitamin D
14%